Browsing by Author Li, Linfeng

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)
2022CBLUE: A Chinese Biomedical Language Understanding Evaluation BenchmarkZhang, Ningyu; Chen, Mosha; Bi, Zhen; Liang, Xiaozhuan; Li, Lei; Shang, Xin; Yin, Kangping; Tan, Chuanqi; Xu, Jian; Huang, Fei; Si, Luo; Ni, Yuan; Xie, Guotong; Sui, Zhifang; Chang, Baobao; Zong, Hui; Yuan, Zheng; Li, Linfeng; Yan, Jun; Zan, Hongying; Zhang, Kunli; Tang, Buzhou; Chen, Qingcai
14-Aug-2023Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myelomaYu, Zhengyu; Qiu, Bingquan; Zhou, Hui; Li, Linfeng; Niu, Ting
2018A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosusLi, Qianwen; Wu, Haijing; Liao, Wei; Zhao, Ming; Chan, Vera; Li, Linfeng; Zheng, Min; Chen, Genhui; Zhang, Jianzhong; Lau, Chak-Sing; Lu, Qianjin
May-2023Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Asian patients with moderate to severe psoriasis: Findings from the phase 3 POETYK PSO-3 and PSO-4 trialsFoley, Peter; Zhang, Jianzhong; Imafuku, Shinichi; Ding, Yangfeng; Okubo, Yukari; Li, Hui; Tada, Yayoi; Li, Linfeng; Ohtsuki, Mamitaro; Pan, Weili; Lu, Yan; Hao, Cheng; Xian, Jiang; Ho, Ji-Chen; Guo, Shuping; Seo, Seong Jun; Napoli, Andrew; Chatterjee, Arkendu; Kisa, Renata M.; Banerjee, Subhashis; Morita, Akimichi
2022EFFICACY AND SAFETY OF CM310 IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2B TRIAL IN CHINAZhang, Jianzhong; Yang, Bin; Li, Jingyi; Ding, Yangfeng; Wu, Liming; Zhang, Litao; Wang, Jinyan; Zhu, Xiaohong; Zhang, Furen; Tao, Xiaohua; Li, Yumei; Zhang, Chunlei; Li, Linfeng; Lu, Jianyun; Diao, Qingchun; Lu, Qianjin; Man, Xiaoyong; Li, Fuqiu; Xia, Xiujuan; Cheng, Hao; Zhao, Yan; Chen, Bo; Yan, Jinchun; Zhao, Guoqing; Jia, Yingmin
2021EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIALZhao, Yan; Wu, Liming; Lu, Qianjin; Gao, Xinghua; Zhu, Xiaohong; Yao, Xu; Li, Linfeng; Li, Wei; Ding, Yangfeng; Song, Zhiqiang; Liu, Lingling; Dang, Ningning; Zhang, Chunlei; Liu, Xiaoming; Gu, Jun; Wang, Jinyan; Geng, Songhai; Liu, Qunazhong; Guo, Yifeng; Lv, Dong; Ren, Gong; Yang, Xiumin; Deng, Danqi; Li, Shanshan; Han, Xiuping; Biao, Shuzhen; Zheng, Min; Dong, Li; Su, Huijuan; Bai, Lili; O'Malley, John T.; Luo, Junxiang; Zhang, Jianzhong
Aug-2022An Efficient Method for Deidentifying Protected Health Information in Chinese Electronic Health Records: Algorithm Development and ValidationWang, Peng; Li, Yong; Yang, Liang; Li, Simin; Li, Linfeng; Zhao, Zehan; Long, Shaopei; Wang, Fei; Wang, Hongqian; Li, Ying; Wang, Chengliang
30-Aug-2022An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signatureYu, Zhengyu; Qiu, Bingquan; Li, Linfeng; Xu, Jing; Zhou, Hui; Niu, Ting
2013Identification of the critical amino acid residues of immunoglobulin E and immunoglobulin G epitopes on alpha(s1)-casein by alanine scanning analysisCong, Yanjun; Yi, Hong; Qing, Yuting; Li, Linfeng
2024In-Situ Polymer Framework Strategy Enabling Printable and Efficient Perovskite Solar Cells by Mitigating "Coffee Ring" EffectLi, Linfeng; Huang, Zengqi; Meng, Xiangchuan; Xing, Zhi; Fan, Baojin; Li, Jiaxuan; Chen, Yiwang
2021LABORATORY SAFETY OF DUPILUMAB AND ITS EFFECT ON INFLAMMATORY BIOMARKERS IN ADULT CHINESE PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND PHASE III STUDYZhao, Yan; Wu, Liming; Lu, Qianjin; Gao, Xinghua; Zhu, Xiaohong; Yao, Xu; Li, Linfeng; Li, Wei; Ding, Yangfeng; Song, Zhiqiang; Liu, Lingling; Dang, Ningning; Zhang, Chunlei; Liu, Xiaoming; Gu, Jun; Wang, Jinyan; Geng, Songmei; Liu, Quanzhong; Guo, Yifeng; Lv, Dong; Ren, Hong; Yang, Xiumin; Deng, Danqi; Li, Shanshan; Han, Xiuping; Biao, Zhenshu; Zheng, Min; Dong, Lichee; Su, Huijuan; Bai, Lili; O'Malley, John T.; Luo, Junxiang; Li, Yi; Wang, Min; Fan, Xinli; Zhang, Jianzhong
30-Mar-2020A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Compound Glycyrrhizin Capsules Combined with a Topical Corticosteroid in Adults with Chronic EczemaXu, Wei; Li, Yan; Ju, Mei; Lai, Wei; Lu, Xueyan; Shi, Huijuan; Shi, Weimin; Gu, Heng; Li, Linfeng
May-2024Power law in species-area relationship overestimates bacterial diversity in grassland soils at larger scalesZhang, Biao; Xue, Kai; Liu, Wenjing; Zhou, Shutong; Nie, Shipeng; Rui, Yichao; Tang, Li; Pang, Zhe; Li, Linfeng; Dong, Junfu; Xu, Cong; Jiang, Lili; Wang, Shaopeng; Hao, Yanbin; Cui, Xiaoyong; Wang, Yanfen
Nov-2023A randomized, double-blind, placebo- controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areataZhou, Cheng; Yang, Xiumin; Yang, Bin; Yan, Guofu; Dong, Xiuqin; Ding, Yangfeng; Fan, Weixin; Li, Linfeng; Yang, Dingquan; Fang, Hong; Ji, Chao; Cheng, Hao; Zhang, Shoumin; Goh, Aik Han; Liu, Rongjun; Gu, Xiaoyu; Weng, Zaili; Foley, Peter; Sinclair, Rodney; Zhang, Jianzhong
2023Rapid response of spesolimab in biologics - failure patient with generalized pustular psoriasis flareJiang, Meng; Li, Yan; Guan, Xin; Li, Linfeng; Xu, Wei
2019Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled studyLiu, Lunfei; Chen, Jisu; Xu, Jinhua; Yang, Qinping; Gu, Chaoying; Ni, Chunya; Li, Linfeng; Lu, Xueyan; Yao, Zhirong; Tao, Jianfeng; Guo, Yifeng; Fang, Hong; Ding, Yingguo; Qiang, Qihong; Zhou, Naihui; Wang, Miaomiao; Deng, Danqi; Xie, Hong; Li, Shenqiu; Huang, Yongchu; Zhao, Naiqing; Zheng, Min
2018The Therapeutic and Pathogenic Role of Autophagy in Autoimmune DiseasesYin, Heng; Wu, Haijing; Chen, Yongjian; Zhang, Jianzhong; Zheng, Min; Chen, Genhui; Li, Linfeng; Lu, Qianjin